Differences in the Expression Levels of SARS-CoV-2 Spike Protein in Cells Treated with mRNA-Based COVID-19 Vaccines: A Study on Vaccines from the Real World

Comirnaty (BNT162b2) and Spikevax (mRNA-1273) COVID-19 vaccines encode a full-length SARS-CoV-2 Spike (S) protein. To evaluate whether the S-protein expressed following treatment with the two vaccines differs in the real-world context, two cell lines were treated for 24 h with two concentrations of...

Descripción completa

Detalles Bibliográficos
Autores principales: Cari, Luigi, Naghavi Alhosseini, Mahdieh, Mencacci, Antonella, Migliorati, Graziella, Nocentini, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144021/
https://www.ncbi.nlm.nih.gov/pubmed/37112792
http://dx.doi.org/10.3390/vaccines11040879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10144021/
https://www.ncbi.nlm.nih.gov/pubmed/37112792
http://dx.doi.org/10.3390/vaccines11040879

Ejemplares similares